Bolt Biotherapeutics (BOLT) Change in Cash (2020 - 2026)

Bolt Biotherapeutics has reported Change in Cash for 7 years, with the latest figure at -$94000.0 in Q1 2026.

• Quarterly Change in Cash fell 107.93% year-over-year to -$94000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 22.72% YoY) and the FY2025 annual result came in at $4.5 million, up 224.02% from the prior year.
• Change in Cash rose to -$94000.0 in Q1 2026 per BOLT's latest filing, from -$6.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $16.6 million in Q1 2022 and troughed at -$21.4 million in Q2 2022.
• A 5-year average of -$917705.9 and a median of -$94000.0 in 2026 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 240.07% in 2024, down 231.45% in 2024.
• Over 5 years, Change in Cash stood at -$1.4 million in 2022, then surged by 220.17% to $1.6 million in 2023, then plunged by 231.45% to -$2.2 million in 2024, then plunged by 180.18% to -$6.1 million in 2025, then jumped by 98.45% to -$94000.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$94000.0, -$6.1 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.